Navigation Links
PharmSource Lead Sheet Adds Coverage of Medical Devices and Diagnostics
Date:12/12/2012

Fairfax, VA (PRWEB) December 11, 2012

PharmSource Information Services, Inc. (PharmSource) has announced that it now offers a concise data-driven resource that delivers targeted business opportunities to companies supporting the medical device/diagnostic arena, worldwide.

This offering, known as the PharmSource Lead Sheet: Devices & Diagnostics Edition, provides pipeline updates regarding medical device and diagnostic candidates in the clinical trial process, as well as approvals and clearances in the US and abroad. Weekly updates signal when medical devices or diagnostics move into a new development stage. Product coverage includes pre-feasibility through post-marketing, acquisitions and alliances. In addition, users are informed company acquisitions and alliances, corporate-level financings and other deals and events that signal corporate expansions or contractions.

The availability of a weekly supply of fresh intelligence on the medical device and diagnostic world in this single-source, user-friendly resource is expected to be a major boon for CROs, CMOs and other companies providing services in this industry.

This resource enables service providers to easily identify new opportunities based on criteria that are relevant to specific needs (i.e., therapeutic specialty; device/diagnostic purpose or type; approval status; class; lifespan; invasiveness; material; and more). Hotlinks go immediately to deeper information about both the product and the company. In addition, verified contacts are provided for each company reported in the weekly report to help business development teams start calls at the right level.

For a limited time, PharmSource is offering a complimentary walk-through of the PharmSource Lead Sheet: Devices & Diagnostics Edition for qualified companies. For more information, contact PharmSource directly at 1-703-383-4903, ext. 112 / info(at)pharmsource(dot)com.

About PharmSource®
PharmSource specializes in bringing together buyers and sellers of contract services related to drug development and manufacturing. Founded in 1996, this globally respected provider of proprietary databases and insightful market intelligence serves clients’ strategic information needs and helps them to be aware of and fully understand critical sourcing factors and make optimal operating and strategic decisions. To learn more, visit PharmSource at http://www.pharmsource.com, or contact info(at)pharmsource(dot)com / phone: 1-703-383-4903 (USA, eastern time-zone).

Read the full story at http://www.prweb.com/releases/PharmSource/Dec2012/prweb10194466.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Northwest Bio Implements Major Balance Sheet Clean-Up
2. UMass Amherst polymer scientists, physicists develop new way to shape thin gel sheets
3. Simple, cheap way to mass-produce graphene nanosheets
4. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
5. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
6. A New Dawn in Cosmetics Coverage: Cosmetics Design Launches Asia-Pacific News Website
7. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
8. DiaTech Life Sciences Announces Medical Advisory Board
9. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
10. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
11. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... 4, 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an ... monetization of intellectual property, today provided an update on ... Northern District of Texas and ... Inter Partes Re-examination ("IPR") proceedings that VTech ... IPR was initiated on only certain claims of two ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
(Date:2/3/2016)... , Feb. 3, 2016 New ... more than $1 million for researchers in ... on health-related research that demonstrates exciting potential.   ... of funding for the New Jersey Health Foundation Research ... members at these educational institutions— Princeton University, Rutgers ...
Breaking Biology Technology:
(Date:1/21/2016)... 2016 --> ... research report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, ... Expression, Voice Recognition and Others), Services, Application Areas, ... 2020", published by MarketsandMarkets, the global Emotion Detection ... 22.65 Billion by 2020, at a CAGR of ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
Breaking Biology News(10 mins):